Jeffrey A. Lieberman, M.D.
Affiliations: | New York State Psychiatric Institute/Columbia University Medical Center, New York, NY, United States |
Google:
"Jeffrey Lieberman"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Trubetskoy V, Pardiñas AF, Qi T, et al. (2022) Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature |
| Stone WS, Phillips MR, Yang LH, et al. (2022) Neurodegenerative model of schizophrenia: Growing evidence to support a revisit. Schizophrenia Research. 243: 154-162 |
| First MB, Lieberman JA. (2022) How should we diagnose schizophrenia: Don't throw the baby out with the bath water. Schizophrenia Research. 242: 81-83 |
| Zoghbi AW, Dhindsa RS, Goldberg TE, et al. (2021) High-impact rare genetic variants in severe schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Paul SM, Breier A, Lieberman JA, et al. (2021) Clinical Trial of New Drug for Schizophrenia. Reply. The New England Journal of Medicine. 384: e105 |
| Lieberman JA, Dishy G. (2021) Milestones in the History of Schizophrenia. A Comprehensive Chronology of Schizophrenia Research: What Do We Know and When Did We Know It Psychiatric News. 56 |
| Stone WS, Cai B, Liu X, et al. (2020) Association Between the Duration of Untreated Psychosis and Selective Cognitive Performance in Community-Dwelling Individuals With Chronic Untreated Schizophrenia in Rural China. Jama Psychiatry |
| Kantrowitz JT, Grinband J, Goff DC, et al. (2020) Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Maes MS, Lu JY, Tiwari AK, et al. (2020) Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia. Drug Development Research |
| Yoshida K, Maciukiewicz M, Zai CC, et al. (2020) Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109952 |